Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Acasti Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - ACASTI PHARMA INC (APO-V)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 May 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Acasti Pharma Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

27 May 2015 Wright Reports 53 $75.00

US MARKET ANALYSIS AND FORECAST. 70 PAGE REPORT PUBLISH QUARTERLY. IN EACH REPORT YOU WILL FIND 12-MONTHS FORECASTS ANALYSIS TARGET PRICE VALUATION RATINGS AND CREUDE OIL DEPENDENCE FOR 7396 US STOCKS.

25 May 2015 Pechala's Reports 85 $1,000.00

ACASTI PHARMA INC (ACST) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 May 2015 Pechala's Reports 1 $25.00

ACASTI PHARMA INC (ACST) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 May 2015 Pechala's Reports 1 $15.00

ValuEngine Industry Report for Medical-generic Drugs(ACST)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

22 May 2015 ValuEngine, Inc. 10 $49.00

TheStreet.com Ratings Stock Report For: ACASTI PHARMA INC (ACST)

17 May 2015 TheStreet.com Ratings 5 $10.00

TheStreet.com Ratings Stock Report For: ACASTI PHARMA INC (ACST)

10 May 2015 TheStreet.com Ratings 5 $10.00

Acasti Pharma Inc. (APO) - Financial Analysis Review

Acasti Pharma Inc. (APO) - Financial Analysis Review Summary Acasti Pharma Inc. (Acasti) is a biopharmaceutical company...

07 May 2015 GlobalData 39 $125.00